Dr. Atif H. Hussein, MD

Dr. Hussein practices at Memorial Regional Hospital (FL) in Hollywood, Florida.

Dr. Hussein's NPI, 1245225143, was assigned on September 16, 2005. Dr. Hussein graduated from American University of Beirut Faculty of Medicine in 1983. Dr. Hussein holds Florida license 60858.

Dr. Hussein's primary practice is Memorial Regional Hospital (FL), at 3501 Johnson St, Hollywood, FL 33021 in Broward County. The practice phone is (954) 276-5401.

Dr. Hussein's primary practice is Memorial Regional Hospital (FL) in Hollywood, Florida. Dr. Hussein is also affiliated with Memorial Regional Hospital. The medical group on file is Memorial Division of High Risk Obstetrics. Dmand AI also links Dr. Hussein to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hussein practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hussein's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hussein is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Hussein's licenses on file in 7 states: Florida, Missouri, New York, Kansas, North Carolina, Michigan and Louisiana.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Hussein treats.

CMS data shows 383 Medicare services from Dr. Hussein across 6 procedure codes in 2024, for 178 Medicare patients. Medicare paid $30,951 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 178 Medicare patients who saw Dr. Hussein in 2024. The largest group is 75 to 84, with 71 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hussein's median patient age at 62, with 62% women.

In 2024, Dr. Hussein wrote 631 Medicare Part D claims for 107 patients. 76% of them were for generic drugs. CMS names the drug for 359 of them, across 20 drugs with 11 or more claims each, at $778,305 in total drug cost. In 2023, CMS named 207 claims across 12 drugs.

Dr. Hussein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hussein as offering telehealth.

Dmand AI links 17 papers to Dr. Hussein, published from 2021 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Protein Kinase Inhibitors, Molecular Targeted Therapy and Antineoplastic Agents. Dr. Hussein has published most often in Int J Mol Sci. Dr. Hussein's most frequent co-authors are Luis E. Raez, MD, Caroline Kamal Abdelmessih Hana, MD, MS and Marc M. Kesselman, DO.

Dmand AI links Dr. Hussein to 10 clinical trials, 5 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Glioblastoma, Gliosarcoma and Cystadenocarcinoma, Mucinous. National Cancer Institute (NCI) sponsors the most, 4. Open Payments lists research payments to Dr. Hussein that name 2 trials.

CMS Open Payments shows 67 general payments to Dr. Hussein from 17 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 55% of the total. SpringWorks Therapeutics, Inc. paid the most, $7,528. It also lists 2 research payments totaling $1,623 from 2016 to 2022, naming 2 clinical trials.

Dmand AI lists 5 awards for Dr. Hussein, most recently CMS Stage 1 EHR in 2012.

Dr. Hussein graduated from American University of Beirut Faculty of Medicine in 1983.

Dr. Hussein is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.